Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Contrast Medium Sparing Strategy Using Automated Carbon Dioxide Injection During PERIpheral Vascular Interventions for PREVENTion of Major Adverse Kidney Events (MAKE): the PeriPREVENT Randomized Controlled Trial

NCT06656988 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT06656988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06656988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Contrast Medium Sparing Strategy Using Automated Carbon Dioxide Injection During PERIpheral Vascular Interventions for PREVENTion of Major Adverse Kidney Events (MAKE): the PeriPREVENT Randomized Controlled Trial
Lead sponsor
University of Leipzig
Phase
Phase 3
Overall status
Recruiting
Start date
April 14, 2025
Completion date
February 28, 2029
Enrollment
1,960 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases, peripheral vascular diseases